C. M. Schlotter

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

C. M. Schlotter, U Vogt, U. Bosse et al. · Breast Cancer Research · 2003 · 71 citations · Full text

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease

Mike W. Helms, Dirk Kemming, Heike Pospisil et al. · British Journal of Cancer · 2008 · 61 citations · Full text

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid

U Vogt, Krzysztof Piotr Bielawski, U. Bosse et al. · Oncology Reports · 2004 · 52 citations

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August, 1997, University of Wisconsin, Madison, WI, USA.1

U Vogt, Krzysztof Piotr Bielawski, C. M. Schlotter et al. · Gene · 1998 · 44 citations

Breast Oncology, Engineering, Cancer Biology +18

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosis

Burkhard Brandt, U Vogt, C. M. Schlotter et al. · Gene · 1995 · 37 citations

Lung Cancers, Breast Oncology, Oncogenic Agent +11